Skip to main content

. 1956 Dec;31(160):452–466. doi: 10.1136/adc.31.160.452

Phenylalanine-restricted Diets in the Treatment of Phenylketonuria

J D Blainey, R Gulliford

PMCID: PMC2012011 PMID: 13395572

452

Images in this article

Fig. 1
on p.453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ACHESON R. M., KEMP F. H., PARFIT J. Height, weight, and skeletal maturity in the first five years of life. Lancet. 1955 Apr 2;268(6866):691–692. doi: 10.1016/s0140-6736(55)91063-1. [DOI] [PubMed] [Google Scholar]
ARMSTRONG M. D., ROBINSON K. S. On the excretion of indole derivatives in phenylketonuria. Arch Biochem Biophys. 1954 Sep;52(1):287–288. doi: 10.1016/0003-9861(54)90115-0. [DOI] [PubMed] [Google Scholar]
ARMSTRONG M. D., TYLER F. H. Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria. J Clin Invest. 1955 Apr;34(4):565–580. doi: 10.1172/JCI103105. [DOI] [PMC free article] [PubMed] [Google Scholar]
BICKEL H., GERRARD J., HICKMANS E. M. Influence of phenylalanine intake on phenylketonuria. Lancet. 1953 Oct 17;265(6790):812–813. doi: 10.1016/s0140-6736(53)90473-5. [DOI] [PubMed] [Google Scholar]
BLAINEY J. D. An improved metabolic bed. Lancet. 1956 Jan 21;270(6908):138–139. doi: 10.1016/s0140-6736(56)91096-0. [DOI] [PubMed] [Google Scholar]
EDWARDS D. A., HAMMOND W. H., HEALY M. J., TANNER J. M., WHITEHOUSE R. H. Design and accuracy of calipers for measuring subcutaneous tissue thickness. Br J Nutr. 1955;9(2):133–143. doi: 10.1079/bjn19550021. [DOI] [PubMed] [Google Scholar]
JERVIS G. A. Studies on phenylpyruvic oligophrenia; phenylpyruvic acid content on blood. Proc Soc Exp Biol Med. 1952 Dec;81(3):715–720. doi: 10.3181/00379727-81-19998. [DOI] [PubMed] [Google Scholar]
Penrose L., Quastel J. H. Metabolic studies in phenylketonuria. Biochem J. 1937 Feb;31(2):266–274. doi: 10.1042/bj0310266. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES